Reply: Clinical and Biological Effects of Mifepristone Treatment for Psychotic Treatment (original) (raw)

References

• Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF (2001a). Rapid reversal of psychotic depression using mifepristone. J Clin Psychopharmacol 21: 516–521.
  Article CAS PubMed Central Google Scholar
• Belanoff JK, Kalehzan M, Sund B, Fleming Ficek SK, Schatzberg AF (2001b). Cortisol activity and cognitive changes in psychotic major depression. Am J Psychiatry 158: 1612–1616.
  Article CAS PubMed Central Google Scholar
• Belanoff JK, Rothschild AJ, Cassidy F, DeBattista C, Baulieu EE, Schold C et al (2002). An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry 52: 386–392.
  Article CAS PubMed Central Google Scholar
• Carroll BJ (2004a). Sertraline and the Cheshire cat in geriatric depression. Am J Psychiatry 161: 759 (author reply 759).
  Article PubMed Central Google Scholar
• Carroll BJ (2004b). Untreated depression and hippocampal volume loss. Am J Psychiatry 161: 1309.
  Article PubMed Central Google Scholar
• DeBattista C, Belanoff JK, Schatzberg AF (2003). C-1073 (mifepristone) vs placebo add on to usual treatment of psychotic major depression. Presented at the 42nd Annual Meeting of the American College of Neuropsychopharmacology. San Juan, Puerto Rico.
  Google Scholar
• DeBattista C, Belanoff J (2004). A double-blind, placebo controlled trial of C-1073 (Mifepristone) in the treatment of psychotic major depression. Presented at the 43rd Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Peurto Rico.
• Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter WZ (2000). The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res 34: 3–10.
  Article CAS PubMed Central Google Scholar
• Flores B, Kenna H, Keller J, Solvason HB, Schatzberg AF (2006). Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology 31: 628–636.
  Article CAS PubMed Central Google Scholar
• Kane JM, Marder SR, Schooler NR, Wirshing WC, Umbricht D, Baker RW et al (2001). Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Arch Gen Psychiatry 58: 965.
  Article CAS PubMed Central Google Scholar
• Keller J, Flores B, Gomez RG, Solvason HB, Kenna H, Williams G et al (2006). Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry 60: 275–281.
  Article CAS PubMed Central Google Scholar
• NY Times Editorial Desk (2003). Disclosure at the Medical Journals, September 30.
• Ohayon MM, Schatzberg AF (2002). Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry 159: 1855–1861.
  Article PubMed Central Google Scholar
• Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA (2004). Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry 55: 301–312.
  Article PubMed Central Google Scholar
• Rothschild AJ, Williamson DJ, Tohen MF, Schatzberg A, Anderson SW, Van Camper LE et al (2004). A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol 24: 365–373.
  Article CAS PubMed Central Google Scholar
• Rubin RT, Carroll BJ (2004). Mifepristone (RU486) in the treatment of psychotic depression: re-evaluation of published data. Neuropsychopharmacology 29(Suppl 1): S203–S204.
  Google Scholar
• Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO (1985). A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res 19: 57–64.
  Article CAS Google Scholar
• Schneider LS, Nelson JC, Clary CM, Newhouse P, Rama KRR, Krishnan Shiovitz T et al (2004). Dr Schneider and colleagues reply. Am J Psychiatry 161: 759–761.
  Article Google Scholar
• Simpson GM, El Sheshai A, Loza N, Kingsbury SJ, Fayek M, Fawzy W (2005). An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression. J Clin Psychiatry 66: 598–602.
  Article CAS PubMed Central Google Scholar
• Wiedemann K, Lauer C, Loycke A, Pollmacher T, Durst P, Macher JP et al (1992). Antiglucocorticoid treatment disrupts endocrine cycle and nocturnal sleep pattern. Eur Arch Psychiatry Clin Neurosci 241: 372–375.
  Article CAS PubMed Central Google Scholar

Download references